Publication Name	World Journal of Gastroenterology
Manuscript ID	19087
Country	Italy

Received	2015-04-29 13:09
Peer-Review Started	2015-05-12 09:15
To Make the First Decision	2015-08-25 16:03
Return for Revision	2015-08-26 14:19
Revised	2015-09-24 16:49
Second Decision	2015-11-09 16:17
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-11-24 17:12
Articles in Press	2015-11-24 17:13
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-12-30 18:15
Publish the Manuscript Online	2016-01-15 14:54

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Adjuvant radiochemotherapy for gastric cancer: should we use prognostic factors to select patients?
Manuscript Source	Invited Manuscript
All Author List	Linda Agolli, Riccardo Maurizi Enrici and Mattia Falchetto Osti
Funding Agency and Grant Number
Corresponding Author	Linda Agolli, MD, Radiation Oncology, Sant’Andrea Hospital, Via di Grottarossa 1035-1039, 00189 Rome, Italy. linda.agolli@gmail.com
Key Words	Gastric cancer; Adjuvant radiotherapy; Prognostic factors; Locally advanced disease; Selected patients
Core Tip	This is a review of the recent literature that analyze the impact of prognostic factors in patients affected by gastric cancer (GC). The results from the principal clinical trials regarding treatment for GC patients are controversial. Adjuvant therapy for locally advanced disease remains undefined in different countries. Prognostic factors can help clinicians to select those patients who can benefit more from combined post-operative therapy with radiochemotherapy and should be considered in the multidisciplinary meetings.
Publish Date	2016-01-15 14:54
Citation	Agolli L, Maurizi Enrici R, Osti MF. Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients? World J Gastroenterol 2016; 22(3): 1131-1138
URL	http://www.wjgnet.com/1007-9327/full/v22/i3/1131.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i3.1131

Full Article (PDF)	WJG-22-1131.pdf
Full Article (Word)	WJG-22-1131.doc
Manuscript File	19087-Review.docx
Answering Reviewers	19087-Answering reviewers.pdf
Audio Core Tip	19087-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	19087-Conflict-of-interest statement.pdf
Copyright License Agreement	19087-Copyright assignment.pdf
Peer-review Report	19087-Peer-review(s).pdf
Scientific Misconduct Check	19087-Scientific misconduct check.pdf
Scientific Editor Work List	19087-Scientific editor work list.pdf